Followers | 561 |
Posts | 39671 |
Boards Moderated | 2 |
Alias Born | 06/08/2006 |
Monday, October 24, 2016 10:48:15 AM
Recent LPCN News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:05:33 PM
- Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results • PR Newswire (US) • 10/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 10:04:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 01:30:11 PM
- Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries • PR Newswire (US) • 10/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 01:35:10 PM
- Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024 • PR Newswire (US) • 10/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 01:35:22 PM
- Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference • PR Newswire (US) • 09/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 01:35:10 PM
- Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek® • PR Newswire (US) • 09/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 03:23:16 PM
- Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 08/27/2024 12:00:00 PM
- Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024 • PR Newswire (US) • 08/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:20:27 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 10:19:03 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/07/2024 08:05:52 PM
- Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study • PR Newswire (US) • 06/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 01:00:30 PM
- Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 • PR Newswire (US) • 06/10/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:48:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:45:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:43:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:41:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:39:17 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM